Capsule
Background
Ooplasmic transfer techniques
Supplier information | Survival information | Pregnancy information | Explanation | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Species | D | R | OT (%) | Fertilized (%) | 2-cell (%) | 4-cell (%) | 6-cell (%) | 8-cell (%) | Blastocyst (%) | ET (%) | pregnancy | Birth | |
Monkey [4] | MII | MI | 42 | 23 (54.8%) | – | – | – | – | – | – | 4 (9.5%) | 3 (7.1%) | – |
Sham MI | 43 | 26 (60.5%) | – | – | – | – | – | – | 0 | 0 | – | ||
Control MI | 37 | 30 (81%) | – | – | – | – | – | – | 0 | 0 | – | ||
MII | MII | 22 | 22 (100%) | – | – | – | – | – | – | 4 (18%) | 4 (18%) | – | |
Sham MII | 18 | 18 (100%) | – | – | – | – | – | – | 3 (16.7%) | 3 (16.7%) | – | ||
Control MII | 24 | 24 (100%) | – | – | – | – | – | – | 6 (25%) | 4 (16%) | |||
Human [1] | MII | MII | 14(100) | 9 (64.3%) | 8 (57.1%) | 8 (57.1%) | 8 (57.1%) | 8 (57.1%) | 4 (28.6%) | 4 (28.6%) | 1 (7.1%) | 1 (7.1%) | amniocyte nDNA and mtDNA fingerprinting |
Human [16] | MII | MII | 22 fused | 15 (68.2%) | – | – | – | 10 (46.4%) | – | 3 (13.6%) | 0 | 0 | amniocyte nDNA and mtDNA fingerprinting |
MII | MII | 48 | 38 (79.17%) | – | – | – | 8(16.7) | – | 5 (10.4%) | 3 (6.3%) | 1 (2.1%) | amniocyte nDNA and mtDNA fingerprinting | |
Control MII | 17 | 9 (52.9%) | – | – | – | 0 | – | – | – | – | – | ||
Human [18] | Cryo_MII | MII | 37 | 26 (70.3%) | – | – | – | – | – | 17 (45.9%) | 2 | 2 (5%) | – |
Human [19] | 3PN | MII | 62 | 44 (80%) | 39 (63%) | – | 39 (63%) | – | – | 39 (63%) | 4 (6.4%) | 4 | amniocentesis and karyotyping |
Human [20] | MII | MII | 26 | – | – | – | – | – | – | – | – | 2 (7.7%) | Confocal microscopy and mtDNA fingerprinting |
Human [21] | MII | MII | 8 | 6 (75%) | 6 (75%) | 5 (62.5%) | 4 (50%) | 2 (25%) | – | 4 (50%) | 2 (25%) | 2 (25%) | – |
MII Control | 4 | 3 (75%) | 3 (75%) | 1 (25%) | – | – | – | – | – | – | – |
Supplier information | Survival information | Pregnancy information | Explanation | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Species | D | R | OT (%) | Fertilized (%) | 2-cell (%) | 4-cell (%) | 6-cell (%) | 8-cell (%) | Blastocyst (%) | ET (%) | pregnancy | delivery | |
Mouse [13] | F1,1-cell | MF1,1-cell | 58 (55%) | 106 | 46 (43.8%) | 11 (10.4%) | – | 9 (8.5%) | 0 | ||||
MF1,1-cell control | 84 | 84 (95.5%) | 39 (44.3%) | – | 38 (43.1%) | 35 (39.8%) | |||||||
Mouse [13] | F1,2-cell | MF1,1-cell | 42 (58%) | 73 | 42 (58%) | 31 (43%) | – | 30 (41.7%) | 17 (23.6%) | ||||
MF1,1-cell control | 92 | 92 (100%) | 13 (14.1%) | – | 1 (1.09%) | 1 (1.09%) | |||||||
Mouse [13] | F1,2-cell | F1.1-cell | 18 (75%) | 24 | 18 (75%) | 2 (0.03%) | – | 9 (8.5%) | 0 | ||||
F1,1-cell control | 73 | 73 (100%) | 72 (98.6%) | – | 68 (93.1%) | 59 (80.8%) | |||||||
Mouse [14] | F1,2-cell,G1 | F1.1-cell,G1 | – | 267 | – | – | – | – | 72 (27%) | ||||
F1,2-cell,G1 | F1.1-cell,G2 | – | 664 | – | – | – | – | 73 (11%) | |||||
F1,2-cell,S | F1.1-cell,S | – | 800 | – | – | – | – | 40 (5%) | |||||
F1,2-cell,G2 | F1.1-cell,G2 | – | 111 | – | – | – | – | 50 (45%) | |||||
F1.1-cell, | – | 315 | – | – | – | – | 221 (70%) | ||||||
F1,2-cell,G1 | MF1.1-cell,G1 | – | 29 | – | – | – | – | 12 (42%) | |||||
F1,2-cell,G1 | MF1.1-cell,S | – | 800 | – | – | – | – | 8 (0%) | |||||
F1,2-cell,G1 | MF1.1-cell,G2 | – | 128 | – | – | – | – | 28 (22%) | |||||
F1,2-cell,S | MF1.1-cell,G2 | – | 1300 | – | – | – | – | 13 (0%) | |||||
F1,2-cell,G2 | MF1.1-cell,G2 | – | 1067 | – | – | – | – | 32 (3%) | |||||
MF1.1-cell, | – | 67,500 | – | – | – | – | 270 (0.4%) | ||||||
F1,2-cell,G1 | CD1.1-cell,G2 | – | 40 | – | – | – | – | 20 (50%) | |||||
F1,2-cell,S | CD1.1-cell,G2 | – | 2600 | – | – | – | – | 26 (0%) | |||||
F1,2-cell,G2 | CD1.1-cell,G2 | – | 89 | – | – | – | – | 46 (52%) | |||||
CD1,2-cell,G2 | CD1.1-cell,G2 | – | 2523 | – | – | – | – | 40 (1.5%) | |||||
CD1.1-cell, | – | 3350 | – | – | – | – | 134 (4%) | ||||||
Mouse [15] | PN | PN | 224 | – | – | – | – | 193 (86.2%) | 106 (47.3%) | 66 (29.5%) | 24 (10.7%) | ||
MII | PN | 419 | – | – | – | – | 306 (73.03%) | 134 (32%) | 91 (21.7%) | 71 (17%) | |||
GV | PN | 224 | – | – | – | – | 109 (48.7%) | 40 (17.9%) | 11 (4.9%) | 5 (2.2%) | |||
PN control | 1114 | – | – | – | – | 1020 (91.6%) | 246 (22.1%) | 135 (12.1%) | 99 (8.91%) |